Target up and up Oil Free Acne Wash Pink Grapefruit Foaming Scrub

Description

Target Up & Up Free Acne Wash Pink Grapefruit Foaming Scrub is a topical formulation designed for the management of acne. The product is packaged in a 6.7 fluid ounce (198.1 mL) container. It is identified by the National Drug Code (NDC) 11673-068-15. The formulation features a foaming scrub texture, which aids in the cleansing of the skin while targeting acne-related concerns.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic or nonteratogenic effects mentioned associated with the use of this drug.

Dosage and Administration

The affected area should be covered with a thin layer of the medication and rinsed thoroughly. Initial treatment should consist of one application per day. Based on the patient's response and as directed by a healthcare professional, the frequency may be gradually increased to two or three times daily. It is important to monitor for signs of excessive drying of the skin.

In the event that bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day to mitigate these effects.

Contraindications

Use of this product is contraindicated in individuals with a history of eye contact. In the event of contact with the eyes, it is imperative to flush thoroughly with water to mitigate potential irritation or injury. No other contraindications have been identified.

Warnings and Precautions

For external use only.

Skin irritation and dryness may be exacerbated when used concurrently with other topical acne medications. It is advised that only one topical acne medication be utilized at a time to minimize the risk of irritation. Healthcare professionals should counsel patients to avoid contact with the eyes; in the event of contact, the affected area should be flushed thoroughly with water.

In cases of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

No specific recommendations for discontinuation of use or further consultation with a healthcare provider are provided in the insert.

Side Effects

For external use only. No specific adverse reactions or side effects have been reported in clinical trials or postmarketing experiences. Patients should be advised to use the product as directed and to consult a healthcare professional if any unexpected reactions occur.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to alleviate symptoms. Monitoring for signs of skin irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Target up and up Oil Free Acne Wash Pink Grapefruit Foaming Scrub (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this medication. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For topical application, it is recommended to initiate treatment with one application daily to minimize the risk of excessive skin drying. Based on the patient's response, the frequency may be gradually increased to two or three times daily, as directed by a healthcare professional. Should any bothersome dryness or peeling occur, the application frequency should be reduced to once daily or every other day.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Safety during pregnancy has not been established for the use of salicylic acid. The use of salicylic acid during pregnancy is generally not recommended due to potential risks to the fetus. There may be a risk of teratogenic effects associated with the use of salicylic acid in pregnant women.

Healthcare providers should be consulted before use in pregnant patients or those planning to become pregnant to discuss potential risks and consider alternative treatment options.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed.

It is important to inform patients that the use of this medication in conjunction with other topical acne treatments may increase the likelihood of skin irritation and dryness. Therefore, if patients experience irritation, they should be instructed to use only one topical acne medication at a time to minimize adverse effects.

Patients should also be cautioned to avoid contact with their eyes. In the event of accidental eye contact, they should be directed to flush the eyes thoroughly with water to alleviate any potential discomfort or damage.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is important to note that the product may stain some fabrics, and care should be taken to avoid contact with such materials.

For optimal storage, the product should be maintained at controlled room temperature. It is recommended to store the product in a cool, dry place, away from direct sunlight and moisture. Special handling precautions should be observed to prevent any spillage or leakage, which could lead to staining.

Additional Clinical Information

The route of administration for the medication is topical. Patients should apply a thin layer to the entire affected area and rinse thoroughly one to three times daily. It is recommended to start with one application daily, gradually increasing to two or three times daily as needed or directed by a clinician. If patients experience bothersome dryness or peeling, they should reduce the application frequency to once a day or every other day.

Clinicians should counsel patients on the potential for skin irritation and dryness, particularly if another topical acne medication is used concurrently. It is advised to use only one topical acne medication at a time to minimize irritation. Patients should avoid contact with the eyes; in case of contact, they should flush thoroughly with water. Additionally, the medication should be kept out of reach of children, and if swallowed, medical assistance or contact with a Poison Control Center should be sought immediately.

Drug Information (PDF)

This file contains official product information for Target up and up Oil Free Acne Wash Pink Grapefruit Foaming Scrub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)